Consequently, this work suggests that N2E4 has the potential for targeting therapy of PDAC, contributes to understanding the NRP2 function in cellular movement and tumor metastasis, and lays a foundation for the future development of NRP2-based targeted therapy for PDAC. Here, NRP2 is linked to neoplasm.